NFSG
ALXO icon

Newbridge Financial Services Group’s ALX Oncology ALXO Stock Holding History

Newbridge Financial Services Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22
Closed -$106 – 1138
2023
Q3 		$106 Hold
22
– – ﹤0.01% 1248
2023
Q2 		$165 Hold
22
– – ﹤0.01% 1294
2023
Q1 		$99 Hold
22
– – ﹤0.01% 1361
2022
Q4 		$248 Hold
22
– – ﹤0.01% 1381
2022
Q3 		$0 Hold
22
– – ﹤0.01% 1375
2022
Q2 		$0 Hold
22
– – ﹤0.01% 1355
2022
Q1 		$0 Hold
22
– – ﹤0.01% 1432
2021
Q4 		$0 Hold
22
– – ﹤0.01% 1405
2021
Q3 		$2K Hold
22
– – ﹤0.01% 1161
2021
Q2 		$1K Hold
22
– – ﹤0.01% 1327
2021
Q1 		$2K Buy
+22
New +$1.73K ﹤0.01% 1152

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Newbridge Financial Services Group's ALXO Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of ALX Oncology (ALXO) in Q4 2023, closing a stake of 22 shares — an estimated $106 sold.

Newbridge Financial Services Group first reported a position in ALXO in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q3 2021. 93 funds tracked by Wall St. Rank hold ALXO as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining ALX Oncology position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 22 ALX Oncology shares in Q4 2023, an estimated $106.
  • Newbridge Financial Services Group first reported a position in ALX Oncology in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's ALX Oncology position peaked at $2K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.